HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NP603, a novel and potent inhibitor of FGFR1 tyrosine kinase, inhibits hepatic stellate cell proliferation and ameliorates hepatic fibrosis in rats.

Abstract
Fibroblast growth factor 2 (FGF-2) and its main receptor FGFR1 have been shown to promote hepatic stellate cell (HSC) activation and proliferation. However, scant information is available on the anti-fibrogenic activity of FGFR1 inhibitors. The aim of this study was to assess the impact of a selective FGFR1 tyrosine kinase inhibitor NP603 on HSC proliferation and hepatic fibrosis. We demonstrated that rat primary HSCs secreted significant amounts of FGF-2, and its tyrosine phosphorylation of FGFR1 was attenuated by NP603. NP603 inhibited HSC activaton by measuring the expression of α-smooth muscle actin (α-SMA) and the production of type I collagen using ELISA. Furthermore, NP603 (25 μM) in vitro strongly suppressed HSC growth induced by FGF-2 (10 ng/ml) and FCS. This effect correlated with the suppression of extracellular-regulated kinase (ERK) activity and its downstream targets cyclin D1 and p21. In addition, PO NP603 (20 mg·kg(-1)·day(-1)) administration significantly decreased hepatic collagen deposition and α-SMA expression in CCl(4)-treated rats. Collectively, these studies suggest that selective blocking of the FGFR1-mediated pathway could be a promising therapeutic approach for the treatment of hepatic fibrosis.
AuthorsNan Lin, Si Chen, Weidong Pan, Linan Xu, Kunpeng Hu, Ruiyun Xu
JournalAmerican journal of physiology. Cell physiology (Am J Physiol Cell Physiol) Vol. 301 Issue 2 Pg. C469-77 (Aug 2011) ISSN: 1522-1563 [Electronic] United States
PMID21543745 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Actins
  • Ccnd1 protein, rat
  • Cdkn1a protein, rat
  • Collagen Type I
  • Collagen Type I, alpha 1 Chain
  • Cyclin-Dependent Kinase Inhibitor p21
  • Indoles
  • NP 603
  • Propionates
  • Protein Kinase Inhibitors
  • smooth muscle actin, rat
  • Fibroblast Growth Factor 2
  • Cyclin D1
  • Tyrosine
  • Carbon Tetrachloride
  • Fgfr1 protein, mouse
  • Receptor, Fibroblast Growth Factor, Type 1
  • Extracellular Signal-Regulated MAP Kinases
  • MAP Kinase Kinase 1
Topics
  • Actins (metabolism)
  • Animals
  • Carbon Tetrachloride
  • Cell Proliferation (drug effects)
  • Cells, Cultured
  • Collagen Type I (metabolism)
  • Collagen Type I, alpha 1 Chain
  • Cyclin D1 (metabolism)
  • Cyclin-Dependent Kinase Inhibitor p21 (metabolism)
  • Dose-Response Relationship, Drug
  • Enzyme-Linked Immunosorbent Assay
  • Extracellular Signal-Regulated MAP Kinases (metabolism)
  • Fibroblast Growth Factor 2 (metabolism)
  • Hepatic Stellate Cells (drug effects, enzymology, pathology)
  • Indoles (pharmacology)
  • Liver (drug effects, enzymology, pathology)
  • Liver Cirrhosis, Experimental (chemically induced, enzymology, pathology, prevention & control)
  • MAP Kinase Kinase 1 (genetics, metabolism)
  • Male
  • Phosphorylation
  • Propionates (pharmacology)
  • Protein Kinase Inhibitors (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Fibroblast Growth Factor, Type 1 (antagonists & inhibitors, metabolism)
  • Signal Transduction (drug effects)
  • Time Factors
  • Transfection
  • Tyrosine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: